Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02275832
Other study ID # REH-57077
Secondary ID
Status Completed
Phase Phase 4
First received October 23, 2014
Last updated April 21, 2015
Start date November 2014
Est. completion date March 2015

Study information

Verified date April 2015
Source Mae Fah Luang University Hospital
Contact n/a
Is FDA regulated No
Health authority Thailand: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for beard enhancement.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Healthy male

Exclusion Criteria:

- serious underlying diseases.

- history of beard/ hair treatment before 6 months

- history of surgery or trauma on beard area.

- history of minoxidil allergy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
3 % Minoxidil lotion

Placebo


Locations

Country Name City State
Thailand MFL University Hospital (Bangkok) Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mae Fah Luang University Hospital

Country where clinical trial is conducted

Thailand, 

References & Publications (3)

Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014 Feb;41(2):149-52. doi: 10.1111/1346-8138.12275. Epub 2013 No — View Citation

Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10. — View Citation

Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012 Oct;95(10):1312-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other The change of hair diameter after 16 weeks from baseline baseline and 16 weeks No
Other Number of participants with adverse events baseline and 16 weeks Yes
Other Patient satisfaction by self-assessment questionnaires baseline and 16 weeks No
Primary The change of global photographic assessment after 16 weeks from baseline baseline and 16 weeks No
Secondary The change in number of hairs after 16 weeks from baseline baseline and 16 weeks No